UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Heteroaryldihydropyrimidine (HAP) and Sulfamoylbenzamide (SBA) Inhibit Hepatitis B Virus Replication by Different Molecular Mechanisms

Scientific reports, 2017-02, Vol.7 (1), p.42374-42374, Article 42374

2017

Volltextzugriff (PDF)

Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial

The Lancet (British edition), 2010-10, Vol.376 (9751), p.1467-1475

2010

Volltextzugriff (PDF)

Identification of the I38T PA Substitution as a Resistance Marker for Next-Generation Influenza Virus Endonuclease Inhibitors

mBio, 2018-05, Vol.9 (2)

2018

Volltextzugriff (PDF)

Class A capsid assembly modulator apoptotic elimination of hepatocytes with high HBV core antigen level in vivo is dependent on de novo core protein translation

Journal of virology, 2024-03, Vol.98 (3), p.e0150223

2024

Volltextzugriff (PDF)

The Hepatitis C Virus Replicon Presents a Higher Barrier to Resistance to Nucleoside Analogs than to Nonnucleoside Polymerase or Protease Inhibitors

Antimicrobial Agents and Chemotherapy, 2008-05, Vol.52 (5), p.1604-1612

2008

Volltextzugriff (PDF)

A Sustainable Material for Sheep's Cheese Wedges Stored under Different Atmosphere Conditions

Foods, 2024-05, Vol.13 (9), p.1423

2024

Volltextzugriff (PDF)

JUMP‐C: A randomized trial of mericitabine plus pegylated interferon alpha‐2a/ribavirin for 24 weeks in treatment‐naïve HCV genotype 1/4 patients

Hepatology (Baltimore, Md.), 2013-08, Vol.58 (2), p.514-523

2013

Volltextzugriff (PDF)

Existence of hepatitis C virus NS5B variants naturally resistant to non-nucleoside, but not to nucleoside, polymerase inhibitors among untreated patients

Journal of antimicrobial chemotherapy, 2008-06, Vol.61 (6), p.1205-1216

2008

Volltextzugriff (PDF)

TLR7 polymorphism, sex and chronic HBV infection influence plasmacytoid DC maturation by TLR7 ligands

Antiviral research, 2018-09, Vol.157, p.27-37

2018

Volltextzugriff (PDF)

Selected Replicon Variants with Low-Level In Vitro Resistance to the Hepatitis C Virus NS5B Polymerase Inhibitor PSI-6130 Lack Cross-Resistance with R1479

Antimicrobial Agents and Chemotherapy, 2008-12, Vol.52 (12), p.4356-4369

2008

Volltextzugriff (PDF)

mRNA Therapeutic Vaccine for Hepatitis B Demonstrates Immunogenicity and Efficacy in the AAV-HBV Mouse Model

Vaccines (Basel), 2024-02, Vol.12 (3), p.237

2024

Volltextzugriff (PDF)

Optimization of Modified Atmosphere Packaging for Sheep's Milk Semi-Hard Cheese Wedges during Refrigerated Storage: Physicochemical and Sensory Properties

Foods, 2023-02, Vol.12 (4), p.849

2023

Volltextzugriff (PDF)

PROPEL: A randomized trial of mericitabine plus peginterferon alpha‐2a/ribavirin therapy in treatment‐naïve HCV genotype 1/4 patients

Hepatology (Baltimore, Md.), 2013-08, Vol.58 (2), p.524-537

2013

Volltextzugriff (PDF)

Antiviral activity, safety, and pharmacokinetics of danoprevir/ritonavir plus PEG-IFN α-2a/RBV in hepatitis C patients

Journal of hepatology, 2011-11, Vol.55 (5), p.972-979

2011

Volltextzugriff (PDF)

Identification of HCV Resistant Variants against Direct Acting Antivirals in Plasma and Liver of Treatment Naïve Patients

Scientific reports, 2017-07, Vol.7 (1), p.4688-10, Article 4688

2017

Volltextzugriff (PDF)

Similar prevalence of low-abundance drug-resistant variants in treatment-naive patients with genotype 1a and 1b hepatitis C virus infections as determined by ultradeep pyrosequencing

PloS one, 2014-08, Vol.9 (8), p.e105569-e105569

2014

Volltextzugriff (PDF)

Nucleolar Relocalization of RBM14 by Influenza A Virus NS1 Protein

mSphere, 2018-11, Vol.3 (6)

2018

Volltextzugriff (PDF)

GT-1a or GT-1b Subtype-Specific Resistance Profiles for Hepatitis C Virus Inhibitors Telaprevir and HCV-796

Antimicrobial Agents and Chemotherapy, 2009-05, Vol.53 (5), p.2129-2132

2009

Volltextzugriff (PDF)

Essential Role of the N-terminal Domain in the Regulation of RIG-I ATPase Activity

The Journal of biological chemistry, 2008-04, Vol.283 (14), p.9488-9496

2008

Volltextzugriff (PDF)

RG7128 Alone or in Combination with Pegylated Interferon-α2a and Ribavirin Prevents Hepatitis C Virus (HCV) Replication and Selection of Resistant Variants in HCV-Infected Patients

The Journal of infectious diseases, 2010-11, Vol.202 (10), p.1510-1519

2010

Volltextzugriff (PDF)

A Novel Immuno-Competitive Capture Mass Spectrometry Strategy for Protein–Protein Interaction Profiling Reveals That LATS Kinases Regulate HCV Replication Through NS5A Phosphorylation

Molecular & cellular proteomics, 2014-11, Vol.13 (11), p.3040-3048

2014

Volltextzugriff (PDF)

A Review of the Preservation of Hard and Semi-Hard Cheeses: Quality and Safety

International journal of environmental research and public health, 2021-09, Vol.18 (18), p.9789

2021

Volltextzugriff (PDF)

Author Correction for Jones et al., "Identification of the I38T PA Substitution as a Resistance Marker for Next-Generation Influenza Virus Endonuclease Inhibitors"

mBio, 2018-11, Vol.9 (6)

2018

Volltextzugriff (PDF)

Mericitabine and ritonavir-boosted danoprevir with or without ribavirin in treatment-naive HCV genotype 1 patients: INFORM-SVR study

Liver international, 2015-01, Vol.35 (1), p.79-89

2015

Volltextzugriff (PDF)

Association study between mannose-binding lectin haplotypes and X gene mutation of hepatitis B virus from treatment naïve patients

Aging (Albany, NY.), 2016-11, Vol.8 (11), p.2862-2870

2016

Volltextzugriff (PDF)

1 – 25 von 230

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(189)
Mit Volltextzugriff
(200)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(131)
Life Sciences & Biomedicine
(113)
Humans
(74)
Biological And Medical Sciences
(39)
Female
(34)
Male
(33)
Hepacivirus - Drug Effects
(32)
Hepatitis C Virus
(32)
Pharmacology & Pharmacy
(32)
Hepacivirus - Genetics
(31)
Medical Sciences
(31)
Antiviral Agents
(30)
Antiviral Agents - Pharmacology
(26)
Infectious Diseases
(26)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(24)
Pharmacology. Drug Treatments
(24)
Adult
(22)
Animals
(22)
Physical Sciences
(22)
Middle Aged
(21)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Heteroaryldihydropyrimidine (HAP) and Sulfamoylbenzamide (SBA) Inhibit Hepatitis B Virus Replication by Different Molecular Mechanisms

Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial

Identification of the I38T PA Substitution as a Resistance Marker for Next-Generation Influenza Virus Endonuclease Inhibitors

Class A capsid assembly modulator apoptotic elimination of hepatocytes with high HBV core antigen level in vivo is dependent on de novo core protein translation

The Hepatitis C Virus Replicon Presents a Higher Barrier to Resistance to Nucleoside Analogs than to Nonnucleoside Polymerase or Protease Inhibitors

A Sustainable Material for Sheep's Cheese Wedges Stored under Different Atmosphere Conditions

JUMP‐C: A randomized trial of mericitabine plus pegylated interferon alpha‐2a/ribavirin for 24 weeks in treatment‐naïve HCV genotype 1/4 patients

Existence of hepatitis C virus NS5B variants naturally resistant to non-nucleoside, but not to nucleoside, polymerase inhibitors among untreated patients

TLR7 polymorphism, sex and chronic HBV infection influence plasmacytoid DC maturation by TLR7 ligands

Selected Replicon Variants with Low-Level In Vitro Resistance to the Hepatitis C Virus NS5B Polymerase Inhibitor PSI-6130 Lack Cross-Resistance with R1479

mRNA Therapeutic Vaccine for Hepatitis B Demonstrates Immunogenicity and Efficacy in the AAV-HBV Mouse Model

Optimization of Modified Atmosphere Packaging for Sheep's Milk Semi-Hard Cheese Wedges during Refrigerated Storage: Physicochemical and Sensory Properties

PROPEL: A randomized trial of mericitabine plus peginterferon alpha‐2a/ribavirin therapy in treatment‐naïve HCV genotype 1/4 patients

Antiviral activity, safety, and pharmacokinetics of danoprevir/ritonavir plus PEG-IFN α-2a/RBV in hepatitis C patients

Identification of HCV Resistant Variants against Direct Acting Antivirals in Plasma and Liver of Treatment Naïve Patients

Similar prevalence of low-abundance drug-resistant variants in treatment-naive patients with genotype 1a and 1b hepatitis C virus infections as determined by ultradeep pyrosequencing

Nucleolar Relocalization of RBM14 by Influenza A Virus NS1 Protein

GT-1a or GT-1b Subtype-Specific Resistance Profiles for Hepatitis C Virus Inhibitors Telaprevir and HCV-796

Essential Role of the N-terminal Domain in the Regulation of RIG-I ATPase Activity

RG7128 Alone or in Combination with Pegylated Interferon-α2a and Ribavirin Prevents Hepatitis C Virus (HCV) Replication and Selection of Resistant Variants in HCV-Infected Patients

A Novel Immuno-Competitive Capture Mass Spectrometry Strategy for Protein–Protein Interaction Profiling Reveals That LATS Kinases Regulate HCV Replication Through NS5A Phosphorylation

A Review of the Preservation of Hard and Semi-Hard Cheeses: Quality and Safety

Author Correction for Jones et al., "Identification of the I38T PA Substitution as a Resistance Marker for Next-Generation Influenza Virus Endonuclease Inhibitors"

Mericitabine and ritonavir-boosted danoprevir with or without ribavirin in treatment-naive HCV genotype 1 patients: INFORM-SVR study

Association study between mannose-binding lectin haplotypes and X gene mutation of hepatitis B virus from treatment naïve patients

Suchergebnisse filtern